Nanjing Julong Science & Technology Co Ltd Class A (300644) fair value: what the stock is really worth
As of Nov 9, 2026: fair value (intrinsic value) of Nanjing Julong Science & Technology Co Ltd Class A stock ¥20.30, price ¥17.61, upside +15.3%, quality 46 out of 100. Rating: undervalued. Calculated from audited financials with 17 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 5, 2026.
How to read this chart
60‑month range ¥10.73 – ¥41.90 · fair‑value band ¥12.13 – ¥26.42 · the ¥17.61 price screens below the ¥20.30 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 5, 2026.
Follow Nanjing Julong Science & Technology Co Ltd Class A in your weekly email
Every Wednesday you see whether Nanjing Julong Science & Technology Co Ltd Class A is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Nanjing Julong Science & Technology Co.,LTD engages in the research and development, production, and sale of new polymer materials and related composite materials in China and internationally.
Show moreShow less
The company offers performance modified plastics, thermoplastic elastomer materials, carbon fiber composite structural parts and components manufacturing and complete machine assembly, and bio-based resource recycled plastic wood profiles.
It also engages in the production and sale of environmentally friendly materials.
Its products are used in the automobiles and new energy vehicles, high-speed rail and rail transit, communications and electronic and electrical, aerospace and low-altitude economy, medical health, environmental protection construction engineering, and other fields.
The company was formerly known as Nanjing Julong Chemical Industrial Co., Ltd. and changed its name to Nanjing Julong Science & Technology Co.,LTD in September 2009. Nanjing Julong Science & Technology Co.,LTD was founded in 1999 and is based in Nanjing, China.
Stock analysis
Nanjing Julong Science & Technology Co Ltd Class A (300644) currently trades at ¥17.61, while our model-based Fair Value estimate is ¥20.30, implying the stock looks roughly 13% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ¥26.60 per share, and 12 of the 17 models we run sit above the ¥17.61 price.
Bear case: the Dividend Discount group reads lowest at ¥4.83, and 5 of the 17 models stay below the price. Data coverage for this calculation is high.
Scenario range: ¥12.13 (bear) to ¥26.42 (bull), the price of ¥17.61 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 46/100 (below-average quality), in the Basic Materials sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Nanjing Julong Science & Technology Co Ltd Class A reported revenue of 2.9B CNY in FY2025 versus 1.7B CNY in FY2021, a compound +14.6%/yr. Reported net income was 132M CNY in FY2025, compounding +42.9%/yr from FY2021.
Key figures
Market cap 1.9B CNY (≈ $292M) Micro · P/E ratio 22.3 · P/S ratio 0.65 · EPS (TTM) ¥0.7900 · Dividend yield 1.4% · Net margin 3.3% · Return on equity 9.5% · Return on assets (EBIT) 4.0% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 34 out of 100 (medium confidence).
What moves the price
The share trades about 54% below its 52-week high and 1% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −41% fair-value upside, at 15%, 300644 screens cheaper than that median.
Fair Value models
Bear¥12.13Fair Value ¥20.30Bull¥26.42
Price ¥17.61 · Upside +15.3%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (¥0.4645 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.58/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+19.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+18.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+20.2%
Start year 2020 (pandemic). Over 10 years: +13.3% a year
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.9%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.
≈ +32.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year≈ +31.5%
Dividend (yield on the price)1.4%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.base effect: 32.3% / 2.0%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.6% → 7%
2025 sits 77% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
⚠ Base effect: the rate starts in the earnings trough around 2020 (starting value 0.30 per share, median 0.84 in 2015 to 2018). It measures the recovery from the trough, not lasting growth.
Compare Nanjing Julong Science & Technology Co Ltd Class A with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 727 stocks
Beats the industry median on 6/13 measures
A mixed picture versus its industry peers.
Valuation
Quality Score46 · Below median
Fair Value upside+15.3% · Above median
Profitability
Return on equity (12 months)9.5% · Above median
Return on assets4.9% · Above median
Net margin (12 months)3.3% · Below median
Operating margin (12 months)0.3% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)22.9% · Above median
Dividend yield (12 months)1.4% · Below median
Balance sheet
Debt / equity0.18× · Above median
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Nanjing Julong Science & Technology Co Ltd Class A Fair Value". https://www.fairvalue-calculator.com/stock/300644
Frequently asked questions
Is Nanjing Julong Science & Technology Co Ltd Class A (300644) overvalued or undervalued?
As of Nov 5, 2026, our model estimates a fair value of ¥20.30 versus a price of ¥17.61, about +15% upside (undervalued).
What is the fair value of 300644?
Our model-based fair value for Nanjing Julong Science & Technology Co Ltd Class A is ¥20.30 (as of Nov 5, 2026), built from audited fundamentals. The current price: ¥17.61.
What is the quality score of 300644?
Nanjing Julong Science & Technology Co Ltd Class A has a Quality Score of 46/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Nanjing Julong Science & Technology Co Ltd Class A (300644)?
Our model-based price target is the fair value of ¥20.30 (as of Nov 5, 2026) from 17 valuation models. Cautious scenario ¥12.13, optimistic scenario ¥26.42. It is a calculation from audited fundamentals, not an analyst target.
What is the Nanjing Julong Science & Technology Co Ltd Class A stock forecast for 2026?
Our models put fair value at ¥20.30, about +15% upside versus a price of ¥17.61 (undervalued). Cautious scenario ¥12.13, optimistic scenario ¥26.42. The calculation is refreshed regularly with new filings.
What is the revenue of Nanjing Julong Science & Technology Co Ltd Class A (300644)?
Nanjing Julong Science & Technology Co Ltd Class A reported trailing-twelve-month revenue of about 3.0B CNY (latest available figure, as of Nov 5, 2026).
Does Nanjing Julong Science & Technology Co Ltd Class A pay a dividend?
Nanjing Julong Science & Technology Co Ltd Class A currently shows a dividend yield of 1.42% relative to its recent price (as of Nov 5, 2026).
How much is the dividend of Nanjing Julong Science & Technology Co Ltd Class A (300644) and when is the ex-dividend date?
Nanjing Julong Science & Technology Co Ltd Class A pays a dividend of ¥0.25 per share a year, a dividend yield of 1.4%. The last ex-dividend date was Jul 6, 2026. A dividend has been paid every year since at least 2018. The payout ratio is 31.6% of earnings. Our assessment: Watch coverage. The dividend isn’t fully covered by free cash flow or earnings, part of it is funded from reserves or debt. Fine for now, but worth watching: if it stays uncovered, the dividend could be cut.
What is the intrinsic value of Nanjing Julong Science & Technology Co Ltd Class A (300644)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Nanjing Julong Science & Technology Co Ltd Class A it is ¥20.30 per share (as of Nov 5, 2026), against a price of ¥17.61. It is the blended result of 17 valuation models in 7 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Nanjing Julong Science & Technology Co Ltd Class A stock overvalued or undervalued in 2026?
As of Nov 5, 2026, 300644 trades below its calculated fair value: price ¥17.61, fair value ¥20.30, a gap of about +15% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 300644?
No. The price is what the market pays today (¥17.61); the fair value is what the company's own numbers justify (¥20.30). For Nanjing Julong Science & Technology Co Ltd Class A the two are ¥2.69 per share apart. That gap is exactly why we show both numbers side by side.
How much is Nanjing Julong Science & Technology Co Ltd Class A worth?
The market values Nanjing Julong Science & Technology Co Ltd Class A at about 1.9B CNY (market capitalisation, as of Nov 5, 2026). Per share that is ¥17.61; our models calculate a fair value of ¥20.30 per share.
What do the bullish and bearish scenarios say about 300644?
Our models span a range for Nanjing Julong Science & Technology Co Ltd Class A: cautious scenario ¥12.13, base ¥20.30, optimistic ¥26.42 per share (as of Nov 5, 2026, price ¥17.61). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 300644?
Nanjing Julong Science & Technology Co Ltd Class A trades at a price-to-earnings ratio of 22.3 (as of Nov 5, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥20.30 is built from several models across several years. Median P/E at fiscal year-end, 5 fiscal years (2021 to 2025), reported earnings: 30.7. Other multiples: P/B 1.8, P/S 0.6, EV/EBITDA 9.3.
How solid is the balance sheet of Nanjing Julong Science & Technology Co Ltd Class A (300644)?
Balance-sheet figures for Nanjing Julong Science & Technology Co Ltd Class A (as of Nov 5, 2026): return on equity 9.5%, debt of 0.18 per unit of equity. They feed the Quality Score of 46/100, which measures business quality independently of the share price.
How far is 300644 from its 52-week high?
Nanjing Julong Science & Technology Co Ltd Class A trades at ¥17.61, about 54% below its 52-week high of ¥38.45 and 1% above the low of ¥17.38 (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of ¥20.30 is for.
Which stocks are comparable to Nanjing Julong Science & Technology Co Ltd Class A?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Nan Ya Plastics Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Nanjing Julong Science & Technology Co Ltd Class A stock attractive at the current price?
The data as of Nov 5, 2026: price ¥17.61, calculated fair value ¥20.30 (+15%), Quality Score 46/100, from 17 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 300644 calculated?
We run Nanjing Julong Science & Technology Co Ltd Class A through 17 models from 7 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ¥20.30 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.7% above its aggregate fair value. Nanjing Julong Science & Technology Co Ltd Class A currently trades 13% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Nanjing Julong Science & Technology Co Ltd Class A (300644)?
The closing price on Nov 9, 2026 was ¥17.61. Our model-based fair value is ¥20.30, about +15% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Nanjing Julong Science & Technology Co Ltd Class A right now?
A fairly wide model range (¥12.13 to ¥26.42) leaves room in how you read the outcome. The price sits in the lower half of our model range, the side with the larger margin of safety. The data supports the verdict: every model runs on fully documented inputs.
Where does the earnings growth of Nanjing Julong Science & Technology Co Ltd Class A (300644) come from?
Earnings per share at Nanjing Julong Science & Technology Co Ltd Class A grew −2.1 % a year from 2014 to 2024. Broken into its drivers: revenue per share +5.5 %, EBIT margin −7.6 %, tax rate +1.0 %, residual (interest, one-offs) −0.6 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Nanjing Julong Science & Technology Co Ltd Class A
How large is the market capitalisation of Nanjing Julong Science & Technology Co Ltd Class A (300644)?
The market capitalisation of Nanjing Julong Science & Technology Co Ltd Class A is 1.9B CNY (≈ $292M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Nanjing Julong Science & Technology Co Ltd Class A (300644)?
The price-to-sales ratio of Nanjing Julong Science & Technology Co Ltd Class A is 0.65 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Nanjing Julong Science & Technology Co Ltd Class A (300644)?
Earnings per share at Nanjing Julong Science & Technology Co Ltd Class A are ¥0.7900 (price ÷ EPS = P/E 22.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Nanjing Julong Science & Technology Co Ltd Class A (300644)?
The dividend yield of Nanjing Julong Science & Technology Co Ltd Class A is 1.4% (payout 31.6%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Nanjing Julong Science & Technology Co Ltd Class A (300644)?
The net margin of Nanjing Julong Science & Technology Co Ltd Class A is 3.3% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Nanjing Julong Science & Technology Co Ltd Class A (300644)?
The return on equity (ROE) of Nanjing Julong Science & Technology Co Ltd Class A is 9.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Nanjing Julong Science & Technology Co Ltd Class A (300644)?
On an EBIT basis the return on assets of Nanjing Julong Science & Technology Co Ltd Class A is 4.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Nanjing Julong Science & Technology Co Ltd Class A (300644)?
The operating margin of Nanjing Julong Science & Technology Co Ltd Class A is 0.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Nanjing Julong Science & Technology Co Ltd Class A (300644)?
Revenue at Nanjing Julong Science & Technology Co Ltd Class A is growing +22.9% versus a year earlier (3y avg +18.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Nanjing Julong Science & Technology Co Ltd Class A (300644)?
Earnings per share at Nanjing Julong Science & Technology Co Ltd Class A are growing −22.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Nanjing Julong Science & Technology Co Ltd Class A (300644) generate?
The free cash flow of Nanjing Julong Science & Technology Co Ltd Class A is −131M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Nanjing Julong Science & Technology Co Ltd Class A (300644) carry?
The net debt of Nanjing Julong Science & Technology Co Ltd Class A is 393M CNY (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Nanjing Julong Science & Technology Co Ltd Class A in the live analysis
One click puts Nanjing Julong Science & Technology Co Ltd Class A on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 5, 2026